Mondaybaccaratchessset，Hims & Hers Health(HIMSbaccaratchessset.US) shares rose. As of press time, the stock rose more than 29% to 18baccaratchessset.85 US dollars, with transaction volume exceeding 15.68 million. The company launched the weight-loss injection GLP-1, which is better than Novo Nordisk (NVO.US)baccaratchesssetWegovy is 85% lower.
